U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07551583) titled 'Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL' on April 21.
Brief Summary: The goal of this clinical research study is to learn if nivolumab plus AVD (doxorubicin, vinblastine, and dacarbazine) can help to control newly diagnosed early-stage non-bulky cHL in pediatric, adolescent, and young adult patients.
The safety of this drug combination will also be studied.
Study Start Date: Oct. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Hodgkin Lymphoma
Intervention:
DRUG: Nivolumab
Given by IV
DRUG: Doxorubicin Hydrochloride
Given by IV
DRUG: Vinblastine
Given by IV
DRUG: D...